MSaarinen
TL3 Regular · Santander, ES
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 31 January 2025 · last posted 4d · groups: journal-club
144 posts, newest first. Showing up to 150.
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #50 · Compounds › Repair & healing peptides · 24 Jul 2026 · 30 likes This follows post #47 rather than contradicting it. What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #88 · Nutrition & Training › Protein & intake · 21 Jul 2026 · 4 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #60 · Practice › Interactions · 18 Jul 2026 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Seven-day rolling means and why weekly readings mislead Replied, post #50 · Outcomes › Progress reports · 17 Jul 2026 · 0 likes Picking up post #47: that is the part I would want checked first. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to…
-
Revisiting: What pooling buys you and what it destroys Replied, post #92 · Evidence › Meta-analyses · 15 Jul 2026 · 15 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Documenting a supplier's response to a discrepancy Replied, post #33 · Sourcing › Vendor reports · 8 Jul 2026 · 17 likes Worth separating two things that post #29 runs together. Multiple services on one lot: agreement across two independent laboratories is stronger than a high number from…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #83 · Evidence › Journal club · 5 Jul 2026 · 0 likes Coming back to post #81, because the follow-up matters more than the original answer. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the…
-
About the Adverse events category Replied, post #5 · Safety › Adverse events · 3 Jul 2026 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Request: a per-category review queue Replied, post #76 · Meta › Feature requests · 3 Jul 2026 · 6 likes Coming back to post #74, because the follow-up matters more than the original answer. Deprecation requests: if you think a feature should be removed or changed, that is…
-
Pooling trials with different estimands Replied, post #65 · Evidence › Meta-analyses · 2 Jul 2026 · 10 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Programming during a large energy deficit Replied, post #47 · Nutrition & Training › Resistance training · 26 Jun 2026 · 5 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #20 · Analytics › Impurities & related substances · 24 Jun 2026 · 28 likes Coming back to post #18, because the follow-up matters more than the original answer. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #47 · Compounds › Oral incretins · 18 Jun 2026 · 0 likes Worth separating two things that post #43 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Bioimpedance and hydration: why the number moves Replied, post #61 · Outcomes › Body composition · 16 Jun 2026 · 0 likes Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent. Useful as a supplementary measure but not as a primary…
-
Submitting a sample: the process end to end Replied, post #18 · Sourcing › Independent verification · 15 Jun 2026 · 0 likes Picking up post #15: that is the part I would want checked first. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Coming back to: Reconciling a supplier certificate with an independent result Replied, post #13 · Sourcing › Vendor reports · 11 Jun 2026 · 0 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #8 · Access › International · 10 Jun 2026 · 4 likes Picking up post #5: that is the part I would want checked first. Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language…
-
Official shortage notices and what they authorise Replied, post #95 · Access › Shortages · 8 Jun 2026 · 10 likes I read post #93 twice before replying, because I had assumed the opposite. Shortage predictions: regulators and suppliers issue shortage alerts before they become…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #3 · Practice › Side effects · 7 Jun 2026 · 2 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #93 · Sourcing › Red flags · 6 Jun 2026 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #37 · Analytics › Impurities & related substances · 5 Jun 2026 · 10 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #13 · Start Here › Welcome · 3 Jun 2026 · 17 likes post #12 is right about the mechanism and I think understates the practical bit. The moderation log is public. Every staff action is logged with the rule cited and the…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #36 · Analytics › Home & field testing · 1 Jun 2026 · 1 like This follows post #33 rather than contradicting it. False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not…
-
Introducing myself and asking whether my planned first topic belongs anywhere — does… Replied, post #3 · Start Here › Welcome · 28 May 2026 · 0 likes This follows post #2 rather than contradicting it. Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #17 · Clinical › Special populations · 20 May 2026 · 7 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #31 · Analytics › Home & field testing · 19 May 2026 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Blind submission and why it changes minds — the long version Replied, post #80 · Sourcing › Independent verification · 17 May 2026 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Prescription portability between countries Replied, post #22 · Access › International · 2 May 2026 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #8 · Analytics › Home & field testing · 1 May 2026 · 20 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Bioimpedance and hydration: why the number moves Replied, post #36 · Outcomes › Body composition · 26 Apr 2026 · 9 likes Worth separating two things that post #32 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #98 · Compounds › Tirzepatide · 26 Apr 2026 · 6 likes I read post #96 twice before replying, because I had assumed the opposite. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance…
-
What other technical communities get right that we do not Replied, post #3 · Lounge › Off topic · 23 Apr 2026 · 0 likes Politics and public policy: healthcare policy that affects access to these compounds is relevant here. Partisan politics is not.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #7 · Compounds › Semaglutide · 23 Apr 2026 · 17 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #33 · Analytics › HPLC & UHPLC · 21 Apr 2026 · 3 likes Worth separating two things that post #29 runs together. Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #12 · Analytics › HPLC & UHPLC · 13 Apr 2026 · 21 likes Coming back to post #10, because the follow-up matters more than the original answer. Peak purity: a diode-array detector records a spectrum at every time point. If a…
-
Journal club: is percentage weight change the right endpoint? Replied, post #62 · Evidence › Journal club · 12 Apr 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
CJC-1295 with and without DAC: what the modification does Replied, post #26 · Compounds › Secretagogues & GH axis · 4 Apr 2026 · 5 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Moderation log format change Replied, post #41 · Meta › Announcements · 2 Apr 2026 · 15 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #27 · Outcomes › Body composition · 22 Mar 2026 · 7 likes post #26 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #73 · Analytics › Mass spectrometry · 18 Mar 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
CJC-1295 with and without DAC: what the modification does Replied, post #13 · Compounds › Secretagogues & GH axis · 14 Mar 2026 · 16 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #34 · Practice › Storage & stability · 14 Mar 2026 · 20 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
-
Oral versus injected administration claims for BPC-157 Replied, post #14 · Compounds › Repair & healing peptides · 13 Mar 2026 · 0 likes On post #10 — agreed on the reasoning, with one qualification. Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one…
-
Splitting a weekly dose in two: the pharmacokinetic argument against Replied, post #28 · Practice › Dosing & titration · 13 Mar 2026 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Time to steady state after a dose increase Replied, post #11 · Pharmacology › Pharmacokinetics · 9 Mar 2026 · 2 likes post #10 answers the question as asked. The question underneath it is different. Individual variation: people vary in how quickly they absorb, distribute, metabolise,…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #115 · Evidence › Study critique · 6 Mar 2026 · 4 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #13 · Outcomes › Progress reports · 4 Mar 2026 · 11 likes post #12 is right about the mechanism and I think understates the practical bit. Exercise volume changes: increasing exercise intensity or duration can mask weight loss…
-
Micro-titration: a disputed topic, argued properly Replied, post #41 · Practice › Dosing & titration · 2 Mar 2026 · 22 likes Coming back to post #39, because the follow-up matters more than the original answer. Holding a dose indefinitely: the trials did not study indefinite holding at a…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #125 · Practice › Dosing & titration · 21 Feb 2026 · 2 likes Picking up post #122: that is the part I would want checked first. Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #33 · Evidence › Trials · 10 Feb 2026 · 15 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Managing an unplanned gap in supply Replied, post #22 · Access › Shortages · 4 Feb 2026 · 3 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #67 · Clinical › Bloodwork · 3 Feb 2026 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: LEADER as the historical anchor Replied, post #27 · Evidence › Journal club · 25 Jan 2026 · 22 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Filter needles: when they help and what they cost you Replied, post #31 · Devices › Syringes & needles · 20 Jan 2026 · 0 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #56 · Clinical › Bloodwork · 20 Jan 2026 · 23 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #42 · Outcomes › Body composition · 19 Jan 2026 · 0 likes post #41 answers the question as asked. The question underneath it is different. Precision versus accuracy: the precision you need depends on what question you are…
-
Liver enzymes drifting down and what that usually means Replied, post #45 · Clinical › Bloodwork · 11 Jan 2026 · 0 likes On post #41 — agreed on the reasoning, with one qualification. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is…
-
A partial dose because the pen emptied mid-injection Replied, post #8 · Practice › Administration · 6 Jan 2026 · 11 likes Picking up post #5: that is the part I would want checked first. A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #37 · Practice › Storage & stability · 17 Dec 2025 · 12 likes This follows post #34 rather than contradicting it. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those are red flags. Faint…
-
The decimal-point error, and the habit that catches it Replied, post #23 · Practice › Reconstitution · 14 Dec 2025 · 32 likes Coming back to post #21, because the follow-up matters more than the original answer. How much of the diluent volume the powder itself displaces: for a small peptide…
-
Reading an interaction checker output critically Replied, post #61 · Practice › Interactions · 8 Dec 2025 · 25 likes post #60 is right about the mechanism and I think understates the practical bit. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #36 · Start Here › How to Ask · 26 Nov 2025 · 0 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Airline travel with a temperature-sensitive injectable Replied, post #16 · Devices › Cold chain · 20 Nov 2025 · 16 likes Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
-
Insomnia at a dose step: reported experiences Replied, post #21 · Wellbeing › Sleep · 31 Oct 2025 · 0 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
-
Conference abstracts as evidence: the weakest common citation Replied, post #6 · Evidence › Preprints · 30 Oct 2025 · 0 likes I read post #4 twice before replying, because I had assumed the opposite. Preprints for speed: some important preliminary findings are posted as preprints to…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #63 · Compounds › Tirzepatide · 22 Oct 2025 · 0 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Pooling trials with different estimands — what changed since Replied, post #40 · Evidence › Meta-analyses · 21 Oct 2025 · 17 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #40 · Safety › Adverse events · 21 Oct 2025 · 0 likes Picking up post #37: that is the part I would want checked first. Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #15 · Start Here › Welcome · 13 Oct 2025 · 1 like Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Titles that describe the question, not the situation Replied, post #119 · Start Here › How to Ask · 11 Oct 2025 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Sleep quality changes during weight loss — what changed since Replied, post #20 · Wellbeing › Sleep · 8 Oct 2025 · 0 likes Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing timing (morning versus evening) might help if nighttime GI…
-
Availability by country, dated, with primary sources Replied, post #12 · Access › International · 6 Oct 2025 · 6 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
A comparison of home results against a laboratory result on the same vial Replied, post #45 · Analytics › Home & field testing · 5 Oct 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #65 · Sourcing › Vendor reports · 30 Sep 2025 · 0 likes post #64 answers the question as asked. The question underneath it is different. Temporal patterns: if results from a supplier were good two years ago but have…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #51 · Evidence › Preprints · 29 Sep 2025 · 3 likes This follows post #48 rather than contradicting it. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi.…
-
Payment method and the leverage it gives you, ranked Replied, post #58 · Sourcing › Payments · 22 Sep 2025 · 0 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #15 · Sourcing › Vendor reports · 13 Sep 2025 · 32 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Pages past their review date, listed Replied, post #30 · Meta › Wiki maintenance · 12 Sep 2025 · 2 likes post #29 is right about the mechanism and I think understates the practical bit. Cross-referencing: if two pages should reference each other but do not, suggesting the…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #35 · Analytics › Mass spectrometry · 10 Sep 2025 · 23 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #50 · Practice › Dosing & titration · 9 Sep 2025 · 2 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Confounding by indication, explained with a concrete example Replied, post #12 · Evidence › Study critique · 1 Sep 2025 · 0 likes post #11 answers the question as asked. The question underneath it is different. Confounding: in observational data, is there a third variable that explains the…
-
Hypertension improvement and when medication needs revisiting Replied, post #25 · Clinical › Comorbidities · 26 Aug 2025 · 32 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #63 · Compounds › Retatrutide · 25 Aug 2025 · 0 likes post #62 answers the question as asked. The question underneath it is different. The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #16 · Analytics › HPLC & UHPLC · 24 Aug 2025 · 0 likes This follows post #13 rather than contradicting it. Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #80 · Evidence › Journal club · 21 Aug 2025 · 2 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
When a preprint is the best available evidence and we say so Replied, post #75 · Evidence › Preprints · 19 Aug 2025 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Started this topic · Evidence › Journal club · 7 Aug 2025 · 45 likes Journal club: is percentage weight change the right endpoint? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing…
-
Gauge and length selection for subcutaneous injection Replied, post #14 · Devices › Syringes & needles · 23 Jul 2025 · 23 likes I read post #12 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Sequence verification for an obscure compound: how it is done Replied, post #96 · Compounds › Other compounds · 18 Jul 2025 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A field-by-field walk through a certificate of analysis Replied, post #90 · Analytics › COA interpretation · 17 Jul 2025 · 4 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #126 · Compounds › Tirzepatide · 3 Jul 2025 · 28 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #39 · Sourcing › Regulatory · 2 Jul 2025 · 11 likes I read post #37 twice before replying, because I had assumed the opposite. Preclinical versus clinical: compounds with strong preclinical data can fail in clinical…
-
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #13 · Wellbeing › Mental health · 1 Jul 2025 · 3 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #18 · Compounds › Semaglutide · 25 Jun 2025 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Cross-border purchase within the EU: the actual rules Replied, post #2 · Access › International · 17 Jun 2025 · 11 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #105 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 0 likes post #104 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Merging two pages that cover the same ground Replied, post #3 · Documentation › Wiki requests · 15 Jun 2025 · 32 likes I read the opening post twice before replying, because I had assumed the opposite. Suggesting content for a page: if you know a maintained page is missing something…
-
Half-life, steady state, and accumulation worked through Replied, post #111 · Pharmacology › Pharmacokinetics · 13 Jun 2025 · 0 likes Coming back to post #109, because the follow-up matters more than the original answer. Albumin binding: semaglutide binds albumin through a fatty side chain, which…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #58 · Devices › Pens & autoinjectors · 5 Jun 2025 · 11 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #6 · Start Here › How to Ask · 25 May 2025 · 1 like Coming back to post #4, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Reading a chromatogram someone posted without axes Replied, post #36 · Analytics › HPLC & UHPLC · 23 May 2025 · 27 likes Worth separating two things that post #32 runs together. Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #4 · Compounds › Semaglutide · 23 May 2025 · 0 likes This follows post #3 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #87 · Clinical › Comorbidities · 17 May 2025 · 1 like Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision about adding compounds in this class depends on the…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #30 · Evidence › Journal club · 11 May 2025 · 1 like PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Asking about a compound your prescriber has not heard of Replied, post #36 · Clinical › Prescriber conversations · 10 May 2025 · 1 like Coming back to post #34, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #129 · Evidence › Journal club · 23 Apr 2025 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #74 · Analytics › Mass spectrometry · 21 Apr 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A well-designed study with a badly written abstract Replied, post #30 · Evidence › Study critique · 18 Apr 2025 · 0 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #75 · Compounds › Semaglutide · 13 Apr 2025 · 6 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
Reading order for a first week here, and what to skip until later Replied, post #72 · Start Here › Welcome · 8 Apr 2025 · 0 likes Coming back to post #70, because the follow-up matters more than the original answer. The moderation log is public. Every staff action is logged with the rule cited and…
-
Antibiotics and a course of something with delayed emptying Replied, post #11 · Practice › Interactions · 29 Mar 2025 · 2 likes Picking up post #8: that is the part I would want checked first. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #31 · Sourcing › Vendor reports · 28 Mar 2025 · 6 likes This follows post #28 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #26 · Practice › Reconstitution · 22 Mar 2025 · 20 likes Picking up post #23: that is the part I would want checked first. A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #19 · Practice › Interactions · 18 Mar 2025 · 22 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
Maintainer handover: how it works Replied, post #69 · Meta › Wiki maintenance · 18 Mar 2025 · 22 likes post #68 answers the question as asked. The question underneath it is different. Authority: if you think a page needs input from someone with specific expertise,…
-
A promotion I argued against, and why I lost Replied, post #137 · Documentation › Doc review · 18 Mar 2025 · 1 like This follows post #134 rather than contradicting it. Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the…
-
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #50 · Pharmacology › Receptor biology · 13 Feb 2025 · 0 likes post #49 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Consistent declarations and why they matter more than clever ones Replied, post #10 · Sourcing › Logistics · 8 Feb 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #36 · Evidence › Journal club · 3 Feb 2025 · 16 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
What changed in 2026, by region Replied, post #112 · Access › International · 31 Jan 2025 · 24 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Telehealth prescribing models in the US Replied, post #51 · Regional › North America · 28 Jan 2025 · 18 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.
-
Revisiting: Holding a dose indefinitely: is there a documented downside? Replied, post #23 · Practice › Dosing & titration · 3 Jan 2025 · 32 likes Worth separating two things that post #19 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #74 · Compounds › Semaglutide · 31 Dec 2024 · 6 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #33 · Practice › Interactions · 28 Dec 2024 · 7 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Second pass at: Regression to the mean in progress reports Replied, post #7 · Research Methods › Statistics · 23 Dec 2024 · 9 likes Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by random chance increases. That is why pre-specifying the…
-
What changed in 2026, by region Replied, post #36 · Access › International · 23 Dec 2024 · 5 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Coming back to: Renal impairment: what the labelling says about dose Replied, post #23 · Clinical › Special populations · 20 Dec 2024 · 1 like Worth separating two things that post #19 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #17 · Safety › Adverse events · 20 Dec 2024 · 0 likes Picking up post #14: that is the part I would want checked first. How to document: date, exact symptom or event, severity, duration, outcome, any medical attention…
-
Body image changing more slowly than the body Replied, post #60 · Wellbeing › Mental health · 18 Dec 2024 · 23 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
-
About the Payments category Replied, post #5 · Sourcing › Payments · 11 Dec 2024 · 32 likes Bank transfer and finality: once a bank transfer is sent, it is final. The money is gone. There is no recourse with the bank if the supplier disappears. That is why…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #24 · Practice › Side effects · 25 Nov 2024 · 24 likes Picking up post #21: that is the part I would want checked first. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #71 · Compounds › Repair & healing peptides · 16 Nov 2024 · 32 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
EMA product information as a primary source — does this still hold? Replied, post #60 · Regional › European Union · 16 Nov 2024 · 2 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #5 · Practice › Side effects · 15 Nov 2024 · 2 likes Worth separating two things that the opening post runs together. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain,…
-
People with a low starting BMI: where the evidence stops Replied, post #8 · Clinical › Special populations · 16 Oct 2024 · 16 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Food noise reducing and the disorientation that can follow Replied, post #21 · Wellbeing › Mental health · 13 Oct 2024 · 3 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
-
A page that has drifted out of date and needs a maintainer Replied, post #15 · Documentation › Wiki requests · 3 Oct 2024 · 9 likes On post #11 — agreed on the reasoning, with one qualification. Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #64 · Analytics › COA interpretation · 24 Sep 2024 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Correlation in a self-tracked dataset: what it can support Replied, post #106 · Research Methods › Statistics · 24 Aug 2024 · 0 likes Coming back to post #104, because the follow-up matters more than the original answer. Relative risk and odds ratios: both compare the rate in one group to the rate in…
-
Correlation in a self-tracked dataset: what it can support Replied, post #9 · Research Methods › Statistics · 20 Aug 2024 · 6 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
How this community labels and discusses unrefereed work Replied, post #114 · Evidence › Preprints · 26 Jul 2024 · 1 like Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #5 · Compounds › Oral incretins · 19 Jul 2024 · 8 likes post #4 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Journal club: FLOW and the renal composite, component by component Replied, post #37 · Evidence › Journal club · 12 Jul 2024 · 13 likes Worth separating two things that post #33 runs together. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…